All info related to kamagra tablets product line by Adjanta Pharma are ready on website, you may to order kamagra tablets online in singapore. kamagra tablets is the top selling sildenafil products online in singapore. Advice- pharmacists from singapore. She advice to buy strattera singapore online cheap. strattera has key ingredient atomoxetine, click link to buy atomoxetine online.
Course of antimicrobial therapy ampicillin 250 mg uses and patients previously.
Latest News

World Diabetes Day Seminar – Research & Innovation

World Diabetes Day on November 14 is a worldwide diabetes awareness campaign. Every year World Diabetes Day reaches more than 1 billion people in over 160 countries and aims to highlight key issues relating to diabetes.

World Diabetes Day this year will be honoured with two concurrent seminars from Diabetes SA. The first seminar will focus on the latest research and innovations for people living with type 1 diabetes and their families, and the second seminar will present two expert speakers focused on informed research for people living with type 2 diabetes and their families.

Concurrent Seminar 1 – Type 1 Diabetes

WDD16-seminarGuest speaker Professor Toby Coates will discuss the latest research and innovation: “Treating diabetes in new ways in SA: islets transplanted in the skin and the new whole pancreas transplants – two unique programs only offered in SA.”

Guest speaker Dr Jessica Stranks will discuss up-to-date diabetes technology: “Technology and Diabetes – to infinity and beyond!”

Event details

  • Date: Wednesday 14 November 2018
  • Time: 6.30pm – 9.00pm. Light refreshments will be provided at 7.30pm
  • Venue: Riverbank Rooms 6, 7 & 8, Adelaide Convention Centre, North Terrace, Adelaide
  • Cost: This seminar is FREE to people registered with the NDSS
  • Click here to book online.

Concurrent Seminar 2 – Type 2 Diabetes

shopping-familyGuest speaker Professor Christopher Rayner will discuss his research into gut function: “A bittersweet story: harnessing nutrients to modify gut function and control diabetes”.

Guest speaker Miriam Henke, Health Psychologist with a special interest in Mind-Body Medicine will discuss: “Mental wellbeing for the whole family: How to best care for yourself and your loved ones when diabetes is a part of your everyday life.

Event details

  • Date: Wednesday 14 November 2018
  • Time: 6.30pm – 9.00pm. Light refreshments will be provided at 7.30pm
  • Venue: Riverbank Rooms 6, 7 & 8, Adelaide Convention Centre, North Terrace, Adelaide
  • Cost: This seminar is FREE to people registered with the NDSS
  • Click here to book online.

In addition, there will be trade displays for people living with type 1 and type 2 diabetes including the different insulin pumps, smart meters and continuous blood glucose monitoring devices.


The National Diabetes Services Scheme (NDSS) is an initiative of the Australian Government administered with the assistance of Diabetes Australia.


Australasian Diabetes Congress 2018

The Australasian Diabetes Congress was held this year from 22–24 August 2018 at the Adelaide Convention Centre. The Australasian Diabetes Congress is a premier event for all health professionals specializing in diabetes, working with people with diabetes or having an interest in diabetes.

This was also a very exciting event for Diabetes SA, as we had an information stand in the exhibition hall, with the potential of reaching lots of health professionals working in the field. Five of our abstracts were accepted, resulting in three poster presentations and two oral presentations.

Click here to see photos from the Congress.

ADEA oral presentations

Diabetes SA had two oral presentations on Thursday 23 August, providing an update about recent work undertaken by the health services team in the culturally and linguistically diverse area, and sick day management in correctional facilities. 

Claire Oliver, Diabetes SA: The learning styles of diabetes education for culturally diverse health care workers and professionals in various cultural primary care settings: the learning from experiences.


Fiona Benton, Diabetes SA: A recommendation for sick day management of adults with diabetes in a correctional facility


Highlights from the Australasian Diabetes Congress 

ADS Clinical Symposium – Development and Implementation of the South Australian Aboriginal Diabetes Strategy (by Trish Evans, Diabetes Educator)

I had the privilege of listening to Kim Morey from Wardliparingga Aboriginal Research Unit at SAHMRI on North Terrace discuss the Development and implementation of the South Australian Aboriginal Diabetes Strategy 2017-2021.

The vision of this strategy is to lessen the burden of type 2 diabetes in Aboriginal people, their families and communities. Kim discussed the disparity of 10 years in life expectancy in Aboriginal people and chronic disease is the leading cause of this.

Highlighting Aboriginal people live with diabetes '2 times the rate of the general population'.

Kim outlined the six high level goals to reduce the impact of type 2 diabetes in the Aboriginal population in the next 5 years:

  1. Reduce the incidence of type 2 diabetes and gestational diabetes.
  2. Detect type 2 diabetes early
  3. Improve diabetes care and reduce its complications
  4. Reduce the impact and incidence of diabetes in pregnancy
  5. Reduce the incidence of and better manage type 2 diabetes among priority groups
  6. Strengthen research, data usage and population health monitoring

This Strategy has been developed by Aboriginal people and has been planned to meet the needs of Aboriginal people who live in South Australia. Click here for more information.

Australian Diabetes Congress 2018 – ADS and ADEA Scientific meeting – Consumers Co-design (by Cathy Whiteley APD)

The ADEA Symposium session on consumers co-design was a fantastic session to highlight the importance of the principles of designing diabetes services and resources with people living with diabetes. The term co-design was coined for consumer involvement in developing services from beginning to end.

It focussed on 'Nothing about us without us' active involvement of consumers setting priorities in design, implementation and evaluation. Presenters were a combination of health professionals and peer supporters working together with the aim to make diabetes less stressful.

The resounding message was that people living with diabetes need to be seen as the experts, sharing their own narrative and the reality of life with diabetes. Together with co-design, this session also had a strong focus on the language used in diabetes stressing that to change the perception of diabetes, language matters.

Australian Diabetes Congress 2018 – ADS/ADEA Joint Clinical Symposium – Exercise as medicine – Nutritional management of exercise in type 1 diabetes (by Anissia Fairlie APD)

I had the opportunity to attend Dr Carmel Smart's presentation on exercise and type 1 diabetes. She discussed the importance of adequate nutrition, hydration and insulin adjustment before, during and after exercise to optimise performance, recovery and safety.

Australian Diabetes Congress 2018 – The Dark Side of Diabetes (by Kimberley Zerk, Diabetes Educator)

The Dark Side of Diabetes, conducted by Prof Jonathan Shaw, head of Clinical Diabetes at Baker Heart and Diabetes Institute explored diabetes-related-cardiovascular complications. CVD is the most important complication of type 2 diabetes. The risk for the development of CVD is even more pronounced in women, those with early-onset diabetes (before 40 years of age), and Indigenous Australians. However, interventions that can significantly reduce cardiovascular risk. Click here to view this report.

Australian Diabetes Congress 2018 – Clinical Management of Diabetes Neuropathy (by Kimberley Zerk, Diabetes Educator)

Eva Feldman, Professor of Neurology at the University of Michigan discussed the Clinical management of diabetic neuropathy in Pre-diabetes and diabetes. She stated that it has long been suspected that glycaemic management, while being a crucial factor in diabetic peripheral neuropathy, is not the only one. Her research has shown that Metabolic syndrome, prompted by obesity and a driver of dyslipidemia, also has a considerable impact. In fact, her study showed that obesity alone can cause neuropathy.

Australian Diabetes Congress 2018 – ADEA Kidney Health in Diabetes – Connecting Chronic Kidney Disease: the link with Diabetes (by Claire Oliver, APD)

Shilpa Jesudason provided a vibrant and practical session highlighting the importance of kidneys and their link with diabetes and cardiovascular disease. The main take-home message for me from this presentation was to think more about the kidneys, as diabetes is the leading cause of Chronic Kidney Disease (CKD).

Australian Diabetes Congress 2018 – ADEA Diabetes Research Foundation Showcase – Optimising mealtime insulin bolusing algorithms (by Claire Oliver, APD)

Kristine Bell provided an overview of her current research into the effect of fat intake on glycaemic response. Kristine presented some emerging data on how the amount of fat in a meal may significantly affect blood glucose response and considerations for insulin adjustments depending on the nutritional composition of a meal.

Australian Diabetes Congress 2018 – ADEA Diabetes Research Foundation Showcase – Not scared of sugar (by Claire Oliver, APD)

Tammie Choi presented interesting information on the delivery of a diabetes program to a Chinese community. Tammie included humorous anecdotes from her own experience as an Australian-trained Dietitian from a Chinese background. The focus was on the delivery style of this program and some key messages for clinicians to consider when providing information to someone from a Chinese background. This is a considerably different approach to how many other cultures prefer to receive information and their involvement in their healthcare.


Latest news in health and diabetes

Changing the conversation about why language matters in diabetes

language-mattersWords can empower people and support self-management, but they can also hurt and make living with diabetes more challenging.

This video, recently launched at the American Association of Diabetes Educators, addresses the stigma associated with diabetes and how the diabetes community can help change the conversation.

Click here to watch the video.

Diabetes Australia releases low carbohydrate position statement

statement-dietThis position statement draws on the latest evidence and provides practical advice and information for people with diabetes considering a low carbohydrate eating plan. 

Diabetes Australia has developed this statement in response to enquiries from people with diabetes, health professionals and the general public.

Click here to find out more.

Do your patients have a chronic condition or care for someone who does?

feedbackAdelaide PHN, Country SA PHN and SA Health are working in partnership to implement HealthPathways South Australia, to support consistent health care.

They are seeking consumers and carers to tell us what they have found useful in managing chronic conditions, for potential inclusion in the HealthPathways South Australia portal. The feedback will also advise on the needs and gaps in support for consumers in managing their chronic condition.

This survey will remain open until Close of Business 5.00pm Friday September 14.

Click here to find out more.

National Diabetes Eye Screening Program

eye-checkToo many Australians living with diabetes are missing out on eye check, even though most vision loss from diabetes can be avoided through early detection and treatment.

Now, thanks to an initial grant from the Australian Government and matching funding from the private sector, a new national program will be established to support development of an electronic eye health record and ensure people registered with the National Diabetes Services Scheme get regular reminders to have their eyes checked.

Click here to find out more.

Global review confirms diabetes elevates cancer risk, especially in women

group-peopleA review that covered data from 47 countries showed that women with type 1 of type 2 diabetes were particularly at risk for cancers of the stomach, mouth, and kidney.

The review showed diabetes is a risk factor for most cancers, and that women with diabetes were 6% more likely than men to develop some form of cancer.

Click here to find out more.

Less insulin for patients with type 2 that add on an SGLT2 inhibitor

insulin-adminA US study analysed clinical impact of SGLT2 inhibitors as an add-on to insulin therapy in patients with type 2 diabetes who do not achieve the glycemic goals.

Click here to find out more.

Ryzodeg listing on the PBS statement

Over 118,000 Australians adults living with both type 1 and 2 diabetes will be able to more easily regulate their blood glucose levels with the August 1 listing of Ryzodeg on the PBS.

Ryzodeg is a combination of ultra-long acting and rapid-acting insulin delivered in a once-daily injection.

Click here to find out more. 


Medical device safety alert


TGA REFERENCE: RC-2018-RN-01123-1 ARTG: 128416

This is a notofication to all users of an optional MiniMedTM remote controller model number MMT-503, to inform of a potential security risk related to the Medtronic MiniMedTM Paradigm™ series insulin pumps when using the corresponding MiniMedTM remote controller.

Problem/Issue Description:

The Medtronic remote controller, which uses a wireless (RF) radio frequency to communicate with your insulin pump, helps in programming a set amount of insulin (or bolus) into your Medtronic pump discreetly while keeping your device concealed.

An external security researcher has identified a potential vulnerability related to the MiniMed™ Paradigm™ family of insulin pumps and corresponding remote controller. The researcher's report states that an unauthorized individual in close proximity of an insulin pump user could potentially copy the wireless radio frequency (RF) signals from the user's remote controller (while they are in the process of delivering a remote bolus) and play those back later to deliver an involuntary bolus of insulin to the pump user. This could lead to potential health risks such as hypoglycemia if additional insulin is delivered beyond the user's insulin requirements.

Click here to see a list of the Medtronic remote controller and compatible Medtronic insulin pump(s) that are vulnerable to this issue.

Several factors must occur for your pump to be vulnerable:

  • The remote option for the pump would need to be enabled. This is not a factory-delivered default, and a user must choose this option.
  • The user's remote controller ID needs to be registered to the pump.
  • The Easy Bolus™ option would need to be turned on and a bolus step size programmed in the pump.
  • An unauthorized individual would need to be in close proximity of the user, with necessary equipment to copy the RF signals activated, when the user is delivering a bolus using the remote controller.
  • The unauthorized individual would need to be in close proximity of the user to play back the RF signals to deliver a malicious remote bolus.
  • The user would need to ignore the pump alerts, which indicates that a remote bolus is being delivered.

Protecting the security of your insulin pump

If you are concerned but want to continue to use the convenience of the remote controller, the following are some precautions you can take to minimize risk:

  • Turn off Easy Bolus™ feature when not intending to use the remote bolus option
  • Be attentive to the pump alerts, especially when the easy bolus option is turned on, and immediately cancel any unintended bolus
  • Do not connect to any third-party devices not authorized by Medtronic

Please note that if you have never programmed a remote controller ID into your pump and never programmed the Easy Bolus™ option, you will not be impacted by this vulnerability.

The MiniMedTM Paradigm™ family of insulin pumps remain safe and effective for diabetes management, so we encourage you to continue your therapy as you normally would and take these precautionary steps if you are concerned.

Additional Information

Medtronic is initiating this action in consultation with the Therapeutic Goods Administration.

Local contact details

At Medtronic, patient safety is our top priority, and we are committed to delivering safe and effective therapies that undergo rigorous clinical, quality, manufacturing and regulatory controls to ensure this for our customers. We appreciate your time and attention in reading this important notification. As always, we are here to support you. If you have further questions or need assistance, please call the Medtronic Diabetes Helpline on 1800 777 808.


Thank you to all who gave so generously to our recent appeal

DSA-Digital-WEBs-250px-1BYour donation will help researchers, like Dr Rebecca Thomson, to continue to investigate the cause of an alarming rise in type 1 diabetes in children.

It's only thanks to the commitment and generosity of our supporters that we've been able to help fund research like Dr Thomson's.

Dr Thomson is hopeful that by following pregnant women and babies who have a close relationship to someone with type 1 diabetes, she will discover what is behind this concerning trend.

As a result of your wonderful support $72,237 was raised which is essential to helping us to conduct research, to look for ways to prevent diabetes, and hopefully, one day, to find a cure. This exceeded our target of $57,805.

This is all Eliza ever hoped for in asking for your help, knowing people were as passionate as she is about research which is crucial to the future of type 1 diabetes.

'It's everything to me, the hope for one day having a cure. For my future kids, for my sister, who has just tested positive to the antibodies. I don't want to watch anyone I love go through this as well. Nobody wants to see kids getting diagnosed.'

Once again the organisation would like to thank everyone for their incredible support and we look forward to keeping you informed of the progress of this project.


Diabetes SA Photography Project

We would like to extend an invitation to our members and community to be part of a photography shoot for material used throughout Diabetes SA. This may include awareness campaigns, annual report, Living magazine, website content etc. Click here to find out more.

Registering your interest

Thank you to all who registered their interest. We will notify successful participants of their involvement in the photo session by Thursday 26 July.


Page 1 of 61